Venu Holding Corporation (VENU) has announced a public offering of 18.75M shares of common stock or pre-funded warrants, along with a warrant for each share sold. The price for each share or ...
Venu Holding Corporation VENU stock fell on Monday after the company announced the pricing of a $75 million underwritten public offering. Public Offering Details On Sunday, the company announced a ...
Relmada Therapeutics, Inc. (Nasdaq: RLMD, 'Relmada” or the 'Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central nervous system indications, today ...
Financing led by new investor Venrock Healthcare Capital Partners, with participation from new and existing investorsProceeds support the achievement of value inflection points for multiple RNA ...
Prediction markets are facing backlash over bets related to war, with Polymarket recently archiving some predictions on ...